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The International Sarcoma Kindred Study (ISKS) was
initiated in 2009 to investigate the prevalence and nat-
ure of heritable risk in sarcoma populations. Sarcomas
affect a younger population than most cancers, and are
associated with some of the most striking known famil-
ial cancer syndromes. For example, the Li-Fraumeni
syndrome (LFS) is a devastating heritable condition,
conferring a 90% lifetime risk of cancer and a 50% risk
of invasive cancer by age 30. LFS is predominantly due
to germline mutations in TP53 and CHEK2. Sarcomas
collectively comprise the most frequent cancer seen in
LFS. The ISKS is recruiting all adult patients diagnosed
with sarcoma in Australia, regardless of family history.
Recently, ISKS opened sites in New Zealand and India,
and plans to open in France later this year.
At June 2011, the ISKS has recruited over 450 adult
sarcoma probands and their families. The average age of
onset of sarcomas in these families is significantly
younger than for sarcomas in the general population
(47y versus 59y in Victorian Cancer Registry). Non-sar-
coma cancers in these families also occur at a younger
age than in the VCR (58y versus 65y, P<0.001). A survey
of recognisable familial cancer patterns identified 56%
without a family history, 23% conforming to the Eeles’
criteria for LF–like syndrome (LFL), and 1% (4 families)
with classic LFS. Another 14% of families have odd pat-
terns of familial clustering without conforming to any
known syndrome. There is a 2.7-fold excess of cases of
Hodgkin’s lymphoma (HL), which is not explained by
radiation exposure. The age of onset of the HL cases is
31y (compared with 42y in the VCR), while the age of
onset of the sarcomas in the HL families is 40y.
A survey is being conducted of the incidence of muta-
tions in TP53 in unselected patients with sarcoma to
determine a) the frequency of true LFS; b) the incidence
of unsuspected de novo mutations.A combination of
sequencing (exons 2-11) and multiplex ligation-depen-
dent probe amplification (MLPA) was used to detect
mutations in TP53. In addition, CHEK2 exon 9 dele-
tions and the del1100C variant were screened. Full pedi-
gree and pathologic information was available on all
subjects.
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